Integer Holdings Corporation (NYSE: ITGR), a U.S.‑based medical‑device manufacturer, has become the focus of several legal actions and shareholder notifications as of mid‑January 2026. The proceedings revolve around alleged securities fraud, potential breaches of fiduciary duties by company officers and directors, and a class‑action lawsuit affecting investors who purchased shares during a defined period.

Securities Fraud Allegations

  • Class‑action lawsuit filed On January 13 2026, a class‑action suit was filed by Berger Montague PC on behalf of investors who bought Integer shares between July 25 2024 and October 22 2025. The suit accuses the company of securities‑law violations, specifically alleging misstatements that led to financial loss for shareholders. Investors are urged to contact the firm no later than February 9, 2026 to seek appointment as a class‑action participant.

  • Law firm reminders Pomerantz LLP, and other plaintiffs’ law firms such as DJS Law Group and BFA Law, have issued multiple reminders to shareholders. These notices advise investors to review the allegations and consider joining the litigation.

  • Potential claims of undisclosed financial information Reports from feeds.feedburner.com indicate that the lawsuit may involve claims of “undisclosed financial information,” suggesting that the company might have failed to disclose material data to the market.

Investigation of Fiduciary Breaches

Grabar Law Office has announced an investigation into whether certain officers and directors of Integer Holdings breached their fiduciary duties. The inquiry is open to shareholders who held shares prior to July 25 2024 and still retain them. Shareholders are encouraged to seek potential corporate reform or other remedies.

Shareholder Communications

  • Levi & Korsinsky notified shareholders of Integer Holdings of a class‑action and related stock information, reinforcing the ongoing litigation status.
  • Investor alerts issued by Pomerantz LLP and other firms emphasize the legal deadline and the importance of timely action for affected investors.

Company Response and Market Context

No official statement from Integer Holdings Corporation’s management or board is recorded in the provided sources. The company’s stock, last reported at $82.74 on January 12 2026, trades on the New York Stock Exchange under ticker ITGR. With a market cap of approximately $2.95 billion and a price‑earnings ratio of 34.95, the company operates in the Health Care Equipment & Supplies sector and specializes in medical devices and power solutions.

Summary

Integer Holdings Corporation is currently entangled in a series of legal disputes centering on securities fraud allegations, potential fiduciary breaches, and class‑action lawsuits affecting investors who purchased shares within a specified period. Shareholders are advised to review the legal filings and deadlines issued by the involved law firms and to consult with legal counsel regarding participation in the litigation.